Literature DB >> 23036651

Socio-demographic factors, health risks and harms associated with early initiation of injection among people who inject drugs in Tallinn, Estonia: evidence from cross-sectional surveys.

Sigrid Vorobjov1, Don C Des Jarlais, Katri Abel-Ollo, Ave Talu, Kristi Rüütel, Anneli Uusküla.   

Abstract

AIM: To explore socio-demographic factors, health risks and harms associated with early initiation of injecting (before age 16) among injecting drug users (IDUs) in Tallinn, Estonia.
METHODS: IDUs were recruited using respondent driven sampling methods for two cross-sectional interviewer-administered surveys (in 2007 and 2009). Bivariate and multivariate logistic regression analysis was used to identify factors associated with early initiation versus later initiation.
RESULTS: A total of 672 current IDUs reported the age when they started to inject drugs; the mean was 18 years, and about a quarter of the sample (n = 156) reported early initiation into injecting drugs. Factors significantly associated in multivariate analysis with early initiation were being female, having a lower educational level, being unemployed, shorter time between first drug use and injecting, high-risk injecting (sharing syringes and paraphernalia, injecting more than once a day), involvement in syringe exchange attendance and getting syringes from outreach workers, and two-fold higher risk of HIV seropositivity.
CONCLUSIONS: Our results document significant adverse health consequences (including higher risk behaviour and HIV seropositivity) associated with early initiation into drug injecting and emphasize the need for comprehensive prevention programs and early intervention efforts targeting youth at risk. Our findings suggest that interventions designed to delay the age of starting drug use, including injecting drug use, can contribute to reducing risk behaviour and HIV prevalence among IDUs.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23036651      PMCID: PMC3566328          DOI: 10.1016/j.drugpo.2012.08.003

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  29 in total

1.  The relationship between early age of onset of initial substance use and engaging in multiple health risk behaviors among young adolescents.

Authors:  R H DuRant; J A Smith; S R Kreiter; D P Krowchuk
Journal:  Arch Pediatr Adolesc Med       Date:  1999-03

2.  Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco.

Authors:  A H Kral; J Lorvick; B R Edlin
Journal:  J Acquir Immune Defic Syndr       Date:  2000-06-01       Impact factor: 3.731

3.  A longitudinal investigation into excess risk for blood-borne infection among young injection drug users (IUDs).

Authors:  Cari L Miller; Steffanie A Strathdee; Kathy Li; Thomas Kerr; Evan Wood
Journal:  Am J Drug Alcohol Abuse       Date:  2007       Impact factor: 3.829

4.  Gender differences in injection risk behaviors at the first injection episode.

Authors:  Vera Frajzyngier; Alan Neaigus; V Anna Gyarmathy; Maureen Miller; Samuel R Friedman
Journal:  Drug Alcohol Depend       Date:  2007-02-05       Impact factor: 4.492

5.  Early-onset drug use and risk of later drug problems.

Authors:  J C Anthony; K R Petronis
Journal:  Drug Alcohol Depend       Date:  1995-11       Impact factor: 4.492

6.  Evaluation of 14 commercial HIV-1/HIV-2 antibody assays using serum panels of different geographical origin and clinical stage including a unique seroconversion panel.

Authors:  R Thorstensson; S Andersson; S Lindbäck; F Dias; F Mhalu; H Gaines; G Biberfeld
Journal:  J Virol Methods       Date:  1998-02       Impact factor: 2.014

7.  AIDS and the new drug injector.

Authors:  S R Friedman; D C Des Jarlais; A Neaigus; A Abdul-Quader; J L Sotheran; M Sufian; S Tross; D Goldsmith
Journal:  Nature       Date:  1989-06-01       Impact factor: 49.962

Review 8.  Contemporary addiction treatment: a review of systems problems for adults and adolescents.

Authors:  A Thomas McLellan; Kathleen Meyers
Journal:  Biol Psychiatry       Date:  2004-11-15       Impact factor: 13.382

9.  Factors associated with premature mortality among young injection drug users in Vancouver.

Authors:  Cari L Miller; Thomas Kerr; Steffanie A Strathdee; Kathy Li; Evan Wood
Journal:  Harm Reduct J       Date:  2007-01-04

10.  Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II.

Authors:  Don C Des Jarlais; Theresa E Perlis; Gerry V Stimson; Vladimir Poznyak
Journal:  BMC Public Health       Date:  2006-03-02       Impact factor: 3.295

View more
  10 in total

1.  Drug use generations and patterns of injection drug use: Birth cohort differences among people who inject drugs in Los Angeles and San Francisco, California.

Authors:  Ricky N Bluthenthal; Lynn Wenger; Daniel Chu; Philippe Bourgois; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2017-04-19       Impact factor: 4.492

2.  Long-term benefits of providing transitional services to youth aging-out of the child welfare system: Evidence from a cohort of young people who use drugs in Vancouver, Canada.

Authors:  Brittany Barker; Jean Shoveller; Cameron Grant; Thomas Kerr; Kora DeBeck
Journal:  Int J Drug Policy       Date:  2020-09-01

3.  An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential.

Authors:  David C Perlman; Ashly E Jordan; Anneli Uuskula; Duong Thi Huong; Carmen L Masson; Bruce R Schackman; Don C Des Jarlais
Journal:  Int J Drug Policy       Date:  2015-04-27

4.  Combined prevention for persons who inject drugs in the HIV epidemic in a transitional country: the case of Tallinn, Estonia.

Authors:  Anneli Uusküla; Don C Des Jarlais; Mait Raag; Steven D Pinkerton; Jonathan Feelemyer
Journal:  AIDS Care       Date:  2014-07-23

Review 5.  Providing comprehensive health services for young key populations: needs, barriers and gaps.

Authors:  Sinead Delany-Moretlwe; Frances M Cowan; Joanna Busza; Carolyn Bolton-Moore; Karen Kelley; Lee Fairlie
Journal:  J Int AIDS Soc       Date:  2015-02-26       Impact factor: 5.396

Review 6.  Hepatitis C bio-behavioural surveys in people who inject drugs-a systematic review of sensitivity to the theoretical assumptions of respondent driven sampling.

Authors:  Ryan Buchanan; Salim I Khakoo; Jonathan Coad; Leonie Grellier; Julie Parkes
Journal:  Harm Reduct J       Date:  2017-07-11

7.  Risk behaviour determinants among people who inject drugs in Stockholm, Sweden over a 10-year period, from 2002 to 2012.

Authors:  Niklas Karlsson; Michele Santacatterina; Kerstin Käll; Maria Hägerstrand; Susanne Wallin; Torsten Berglund; Anna Mia Ekström
Journal:  Harm Reduct J       Date:  2017-08-16

8.  Polydrug Use and Heterogeneity in HIV Risk Among People Who Inject Drugs in Estonia and Russia: A Latent Class Analysis.

Authors:  Isabel Tavitian-Exley; Marie-Claude Boily; Robert Heimer; Anneli Uusküla; Olga Levina; Mathieu Maheu-Giroux
Journal:  AIDS Behav       Date:  2018-04

9.  Another frontier for harm reduction: contraceptive needs of females who inject drugs in Estonia, a cross-sectional study.

Authors:  Anneli Uusküla; Mait Raag; Sigrid Vorobjov; Don Des Jarlais
Journal:  Harm Reduct J       Date:  2018-03-05

10.  Transition from First Drug Use to Regular Injection among People Who Inject Drugs in Iran.

Authors:  Masoomeh Koozegar; Armita Shahesmaeili; Mehdi Noroozi
Journal:  Addict Health       Date:  2018-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.